News
Colossal Biosciences Acquires Viagen Pets & Equine
Company Context
- Company Value
- $10.32B
- Market
- Biotech
- Stage
- Growth
Key Highlight
Colossal Biosciences raised an additional $120 million in September 2025, bringing its value to $10.32 billion.
More from Colossal
More Biotech News
- MinicircleKlotho Gene Therapy launching in 2026Mar 2026
- AetherRaised $15M to reindustrialize America with AI-designed proteinsDec 2025
- Latus BioAnnounced IND Clearance of LTS-101 for CLN2 DiseaseDec 2025
- Latus BioLaunched AI/ML Strategy to Transform AAV Gene TherapyNov 2025
- MENTEN AIAndrea McNeal joined as VP of Business DevelopmentOct 2025